Deletion of sphingosine kinase 2 attenuates cigarette smoke-mediated chronic obstructive pulmonary disease-like symptoms by reducing lung inflammation. (2023). Biomolecules and Biomedicine, 23(2), 259–270. https://doi.org/10.17305/bjbms.2022.8034